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Abstract From hemocytes of the tunicate Halocynthia au-
rantium we purified a new antimicrobial peptide named
halocidin. The native peptide had a mass of 3443 Da and
comprised two different subunits containing 18 amino acid
residues (WLNALLHHGLNCAKGVLA) and 15 residues
(ALLHHGLNCAKGVLA), which were linked covalently by a
single cystine disulfide bond. Two different monomers were
separately synthesized and used to make three additional
isoforms (15 residue homodimer, 18 residue homodimer,
heterodimer). In antimicrobial assays performed with synthetic
peptides of halocidin, it was confirmed that congeners of the 18
residue monomer were more active than those of the 15 residue
monomer against methicillin-resistant Staphylococcus aureus
and multidrug-resistant Pseudomonas aeruginosa. / 2002
Published by Elsevier Science B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
In recent years overuse of antibiotics has resulted in the
rapid evolution of multiple drug-resistant bacteria, which
have caused a variety of incurable infectious diseases. In the
hope of inventing novel antimicrobial agents to control the
increasing antibiotic-resistant bacteria, many cationic antimi-
crobial peptides have been isolated from diverse organisms
over the last two decades [1^4]. It has been considered that
the target of most antimicrobial peptides is the speci¢c lipid
bilayer of the bacterial membrane. This mechanism of action
suggested that antimicrobial peptides might have an essential
structure for attacking the bacterial membrane and retain
their antimicrobial activities against resistant bacteria to con-
ventional antibiotics, and also have minimal toxicity towards
human cells [5]. Although much information has accumulated
on the relationship between function and structure of antimi-
crobial peptides, search of natural peptides is still striving to
identify a novel structure with omni-potency against a wide
variety of pathogenic antibiotic-resistant bacteria.
Recently, we isolated an antimicrobial peptide, named ‘di-
cynthaurin’, from the hemocytes of the tunicate, Halocynthia
aurantium [6]. Di-cynthaurin contains an unpaired cysteine
and forms a covalent homodimer, each monomer consisting
of 30 amino acid residues. Here we report another antimicro-
bial peptide, ‘halocidin’, which is puri¢ed from the same
source as di-cynthaurin. Halocidin also has a dimer structure,
which is formed via a disul¢de linkage between cysteines of
two di¡erent sized monomers. This paper describes the puri-
¢cation and characterization of halocidin, and also contains
data to allow comparison of the antimicrobial activities of
halocidin and its congeners against two antibiotic-resistant
bacteria with those of other previously known peptides.
2. Materials and methods
2.1. Puri¢cation of antimicrobial peptide from hemocytes of tunicates
Halocidin was isolated and puri¢ed from acid extracts of tunicate
hemocytes that were prepared as described in previous works [6^8].
Brie£y, living H. aurantium were purchased at a local sea market in
Sockcho, South Korea. Their tunics were washed lightly with 70%
ethanol, blotted dry and transected peribasally. The hemolymph was
collected dripwise into a 50 ml test tube containing 150 mg of dry
ethylenediaminetetraacetic acid. The collected material was pooled,
passed through a sterile 74 Wm mesh ¢lter (Netwell, Corning Costar,
Cambridge, MA, USA) and centrifuged at 300Ug for 10 min at 4‡C.
The hemocytes were resuspended in 30 ml of 0.34 M sucrose and then
re-centrifuged as above. The recovered cells were resuspended in 10 ml
of ice-cold 5% acetic acid, brie£y sonicated and then 40 ml of 5%
acetic acid was added. Thereafter the mixture was stirred overnight at
4‡C and centrifuged at 20 000Ug for 30 min at 4‡C. The supernatant
was used as a starting material to purify antimicrobial peptides.
A sample of supernatant containing at least 50 mg protein was
loaded on a Sephadex G-50 gel ¢ltration column equilibrated with
5% acetic acid. Each fraction from gel chromatography was tested
for antibacterial activity in an ultrasensitive radial di¡usion assay
[9] and the active fractions were pooled and concentrated for further
puri¢cation steps by preparative acid urea (AU)^polyacrylamide gel
electrophoresis (PAGE) [10]. The AU^PAGE eluates were collected in
2 ml fractions and concentrated by vacuum centrifugation (Centra
Evaporator, Bioneer, Korea). Every tenth fraction was electrophores-
ed on duplicate AU^PAGE gels. One gel was stained with Coomassie
blue for monitoring the band and the other was used to identify
antimicrobial activity of protein bands in a gel overlay assay [11].
Active fractions from preparative AU^PAGE were pooled and ¢nally
subjected to C18 reversed-phase (RP) HPLC column (Vydac
218TP54: The Separation Group, Hesperia, CA, USA). HPLC frac-
tions were eluted in various linear gradients of acetonitrile containing
0.1% tri£uoroacetic acid. For the ¢rst 10 min after loading sample, the
column was washed with 5% acetonitrile at £ow rate of 0.5 ml/min.
Next the acetonitrile concentration was linearly increased by 1%/min
for 60 min. Throughout the overall puri¢cation steps, we used a
methicillin-resistant Staphylococcus aureus (MRSA-CCARM3001) in
radial di¡usion assays to con¢rm the antimicrobial activities of frac-
tions.
2.2. Peptide characterization and synthesis
Lyophilized native halocidin was dissolved in 25 Wl of 8 M urea and
25 Wl of 0.4 M ammonium bicarbonate, pH 8.0. Next 5 Wl of 45 mM
dithiothreitol was added to the mixture and incubated at 50‡C for
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Fig. 1. Puri¢cation and MALDI mass spectrometric analysis of halocidin. A: C18 RP-HPLC as a ¢nal step to purify halocidin. Arrow indi-
cates the peak including halocidin. B: AU^PAGE showing stages of puri¢cation. Lane 1, crude extracts of hemocytes; lane 2, active fractions
from gel ¢ltration; lane 3, active fractions from preparative AU^PAGE; lane 4, puri¢ed halocidin from RP-HPLC. C: MALDI mass analysis.
The major peak appeared at m/z value of 3443.68 and two minor peaks at 1515.74 and 1929.91. D: Tricine SDS^PAGE gel with puri¢ed halo-
cidin. Lane M, standard molecular weight markers; lane 1, natural (unreduced) halocidin; lane 2, halocidin reduced with dithiothreitol. PAGE
gels were stained with Coomassie blue.
Table 1
Molecular masses (Da) of natural and synthetic peptides
Peptide Calculated mass MALDI mass
Natural halocidin 15 monomer 1515.9 1515.74
18 monomer 1929.4 1929.91
heterodimer 3443.3 3443.68
Synthetic halocidin 15 monomer 1515.9 1515.70
18 monomer 1929.4 1928.92
15 homodimer 3029.8 3031.07
18 homodimer 3856.8 3861.06
heterodimer 3443.3 3445.04
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15 min. To prepare vinylpyridine derivatives of halocidin monomers,
15 Wl of vinylpyridine was added to the mixture that was cooled to
room temperature and incubated in the dark for at least 30 min. Final
reaction products were puri¢ed by RP-HPLC. Amino acid sequences
of halocidin monomers were separately determined by gas-phase Ed-
man degradation with a Procise 491 (Applied Biosystems, USA) in-
strument. The molecular mass of puri¢ed halocidin was measured by
a matrix-assisted laser desorption ionization (MALDI) mass instru-
ment (Voyager-DE STR, PerSeptive Biosystems, USA).
Two monomers (18 residue monomer and 15 residue monomer) of
halocidin were separately synthesized by using the automated solid-
phase peptide synthesizer (Pioneer, Applied Biosystems, USA) in the
Korea Basic Science Institute and repuri¢ed by RP-HPLC to close to
homogeneity. To prepare dimer forms, two synthetic peptides (1 mg/
ml each) were mixed in 0.1 M ammonium bicarbonate and the mix-
ture was left to stand open to the atmosphere for more than 72 h.
Finally, synthetic halocidin congeners were puri¢ed by RP-HPLC,
and each peak was identi¢ed by measuring its molecular mass by
MALDI mass spectrometry.
2.3. Antimicrobial and hemolytic activity
Antimicrobial activities of peptides were measured in radial di¡u-
sion [9] and colony count assays [12]. For radial di¡usion assay, stock
peptides solutions were prepared in acidi¢ed distilled water (0.01%
acetic acid) and 5 Wl samples were introduced as a series of six serial
two-fold dilutions. These ranged in concentration from 3.12 to 200 Wg
of peptide/ml and loaded into the wells (3 mm in diameter) in the
underlay, in which washed mid-logarithmic phase bacteria were
trapped. The underlay agars consisted of sterile citrate phosphate
bu¡er (9 mM sodium phosphate, 1 mM sodium citrate, pH 7.4), 1%
(w/v) type I (low electroendosmosis) agarose (A 6013; Sigma), and 3%
tryptic soy broth (TSB: Difco, Detroit, MI, USA). After allowing 3 h
for di¡usion of peptides into underlay gels, a 10 ml nutrient-rich
overlay gel containing 6% TSB and 1% agarose was poured. After
the plates were incubated overnight to allow surviving bacteria to
form colonies, the diameters of clearing zones, indicating antibacterial
activity, were plotted against the log10 of the peptide concentrations.
For colony count assay, peptides were mixed to ¢nal concentration of
5 Wg/ml with mid-logarithmic phase MRSA (CCARM3001) or multi-
drug-resistant Pseudomonas aeruginosa (MDRPA-CCARM2002) in a
sterile 10 mM sodium phosphate bu¡er (pH 7.4) containing 0.3 mg/ml
of TSB powder. The mixtures, typically in a ¢nal volume of 100 Wl,
were incubated for the pre-determined times (5 min and 15 min) at
37‡C in a shaking water bath and 20 Wl aliquots were directly removed
at each interval and plated on 1.5% Bacto-agar (Difco). The resulting
colonies were counted after an overnight incubation. Both antimicro-
bial assays were repeated at least three times and mean values were
used to make a graph. Magainin 1 and buforin 2 purchased from
Sigma were used as standard peptides.
For hemolytic assay, 20 Wl of peptides at pre-determined concen-
tration was added to 180 Wl of a 2.5% (V/V) suspension of human
erythrocytes in phosphate-bu¡ered saline (PBS). Melittin (Sigma), a
hemolytic and K-helical peptide from bee venom, was used as positive
control sample. The mixture was incubated for 30 min at 37‡C and
600 Wl of PBS was added to each tube. After centrifugation at
10 000Ug for 3 min, the supernatant was removed and the absorbance
measured at 540 nm.
2.4. Other methods
A Model Mini-Protean 3 Cell (Bio-Rad) was used to perform Tri-
cine SDS^PAGE [13] and AU^PAGE [14]. Peptide concentrations
were measured with bicinchoninic acid (Sigma).
3. Results
3.1. Puri¢cation of halocidin
Halocidin was puri¢ed from acid extracts of H. aurantium
hemocytes by a consecutive three-step procedure consisting of
gel permeation chromatography, preparative AU^PAGE and
RP-HPLC. Fig. 1A shows the RP-HPLC pro¢le of active
fractions eluted from the electrophoresis step that was espe-
cially powerful and a¡orded substantially pure halocidin (Fig.
1B). Halocidin was eluted at a retention time of 50.2 min
corresponding to 45.2% acetonitrile.
3.2. Characteristics of halocidin
MALDI mass analysis of puri¢ed peptide showed three
peaks with the predominant one having a mass of 3443.68
and the two less dominant ones having masses of 1929.91
and 1515.74 (Fig. 1C), suggesting halocidin has a dimer
form as seen previously for di-cynthaurin [6]. This conclusion
was con¢rmed by Tricine SDS^PAGE performed with non-
reduced and reduced halocidin (Fig. 1D). Moreover, two
peaks were detected in the pro¢le of RP-HPLC used to re-
purify the reduced and modi¢ed peptides for amino acid se-
quencing (data not shown). Fig. 2 shows the primary structure
Fig. 2. Primary sequences of two subunits of halocidin. The sequen-
ces are shown in standard single letter code. Vertical bar represents
a disul¢de bond between cysteine residues of the 18 residue mono-
mer and the 15 residue monomer.
Fig. 3. RP-HPLC pro¢les with synthetic and natural halocidins.
Each HPLC was performed in the same condition as in the puri¢ca-
tion of natural peptide. A: Two synthetic monomers, 15 monomer
and 18 monomer, were eluted at 36.8% and 46.3% acetonitrile, re-
spectively. B: Two homodimers, 15 homodimer and 18 homodimer,
were eluted at 39.2% and 51.7% acetonitrile, respectively. The heter-
odimer, equivalent to natural halocidin, was eluted at the same con-
centration of acetonitrile as natural one. C: Natural halocidin was
re-puri¢ed with RP-HPLC.
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of halocidin. Our database search revealed that the amino
acid sequence of halocidin is not homologous to that of any
other known protein, indicating halocidin is a new peptide.
Halocidin consists of two subunits that contain 18 and 15
residues, named 18 monomer and 15 monomer in this paper.
Two monomers are linked by a single disul¢de bond between
the 12th Cys of the 18 monomer and the 9th Cys of the 15
monomer. In the case of many antimicrobial peptides includ-
ing clavanins [7], styelins [8] and di-cynthaurin [6] from tuni-
cates, they are C-terminally amidated. Therefore, we prepared
synthetic peptides of the two monomers, each having an ami-
dated C-terminal alanine. The measured masses of two syn-
Fig. 4. Radial di¡usion assays for antimicrobial activities of halocidin congeners against MRSA and MDRPA. Diameters of clearing zone have
been expressed in units (1 mm=10 units). The regression lines were computer generated, using a least-mean-squares program. Upper panels
show photos of gels in radial di¡usion assays. Numbers represent the concentration (Wg/ml) of peptides loaded in each well. a: 15 monomer;
b: 15 homodimer; c: 18 monomer; d: 18 homodimer; e: heterodimer; f: magainin 1; g: buforin 2. Antibiotic-resistant strains were obtained
from the Culture Collection of Antibiotic Resistant Microbes (CCARM) at Seoul Women’s University in Korea.
Fig. 5. Antimicrobial activities of peptides in colony count assay. Instead of peptides, an equivalent volume of 0.01% acetic acid to sample was
added to each tube for control. Note 18 monomer and homodimer showed stronger activities than heterodimer after incubation for 5 min and
15 min, and standard peptides have little activity against both bacteria.
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thetic peptides almost agreed with those of their correspond-
ing native forms and had the values calculated for the ami-
dated forms (Table 1). Moreover the synthetic halocidin (het-
erodimer) consisting of two di¡erent monomers appeared at
the same retention time (50.16 min: 45.16% acetonitrile) on
RP-HPLC as the natural halocidin (Fig. 3).
3.3. Biological activities
We compared the abilities of synthetic halocidin congeners,
which are 18 monomer, 15 monomer, 18 homodimer, 15 ho-
modimer and heterodimer, with those of standard peptides,
magainin 1 and buforin 2, to kill mid-logarithmic phase
MRSA and MDRPA. While all peptides except the 15 mono-
mer showed strong activities against MDRPA, only three pep-
tides (18 monomer, 18 homodimer and heterodimer) appar-
ently maintained their activities against MRSA in a radial
di¡usion assay (Fig. 4). In addition, our colony count assay
revealed that 18 monomer, 18 homodimer and heterodimer
reduced the number of viable MRSA by more than 3log10^
5log10 bacteria in 5 min, and viable MDRPA by more than
log10^3log10. In contrast, other two standard peptides had no
activity against both antibiotic-resistant bacteria even after
15 min incubation (Fig. 5). The hemolytic e¡ects of halocidin
congeners are shown in Fig. 6. Whereas 100 Wg/ml of 18
monomer and 18 homodimer disrupted 8% and 16% of hu-
man erythrocytes, respectively, an equal concentration of oth-
er synthetic congeners of halocidin lacked hemolytic activity.
4. Discussion
In general, it has been reported that most antimicrobial
peptides are positively charged and exert their activities by
adapting to the anionic properties of bacterial cell envelopes.
A number of studies showed that basic amino acids play a
critical part in the mechanism of action of antimicrobial pep-
tides as they attack bacterial cell membranes [15]. Each sub-
unit of halocidin also has three basic amino acid residues
(Fig. 2), which might contribute to the cationicity of haloci-
din. Compared with other cationic antimicrobial peptides,
halocidin has relatively less positive net charge owing to its
two histidines that have the smallest pKa (about 6.5) of three
cationic residues (Arg, Lys, His). Nevertheless halocidin re-
tained a strong potency against MRSA and MDRPA in our
two assay systems at pH 7.4. Moreover, it has been recently
shown that many staphylococcal strains are resistant to the
antimicrobial peptides [16,17], and established that the pep-
tide-resistant bacteria neutralize the negatively charged groups
of the cell wall by esterifying with the amino group of D-ala-
nine, the latter reaction results in decreased interactions with
cationic peptides [18]. Judging from the cationicity of haloci-
din and its activity against MRSA, we postulate therefore that
halocidin may have an additional structural motif besides its
cationicity, which is important for interaction with the bacte-
rial cell wall.
Interestingly, halocidin has an intermolecular disul¢de link-
age, which is also con¢rmed in the structure of di-cynthaurin,
an antimicrobial homodimeric peptide isolated from hemo-
cytes of H. aurantium in our previous work [6]. Although
halocidin is a heterodimeric peptide, unlike di-cynthaurin, its
large subunit di¡ers from the small one only by containing
three additional N-terminal amino acid residues (Trp-Leu-
Asn). Our antimicrobial assays revealed that 15 monomer
and 15 homodimer were much less active than other halocidin
congeners with an extra N-terminal part. What is the reason
for the di¡erence of activities between 15 monomer and 18
monomer congeners? We think one answer might be provided
by a Trp residue at the N-terminus of the 18-mer. It is gen-
erally considered that the positioning of an aromatic residue
at the N-terminal site is important for the antimicrobial ac-
tivity of the peptide [19]. For instance, in the case of cecro-
pins, well-known antimicrobial peptides from insects, it is
con¢rmed that the exchange of Trp, the second amino acid
of the N-terminal part, with a charged residue resulted in a
prominent decrease of antibacterial activity [20]. On the other
hand, our colony count assay revealed that halocidin conge-
ners act much faster on bacteria than buforin 2 which requires
introduction into the cell for its activity [21]. Taken together,
although it is too early to determine the action mechanism of
halocidin from our present data, we surmise that the main
target of halocidin, like many other antimicrobial peptides
including cecropins, might be the bacterial cell membrane [22].
Although we have not presented the antimicrobial spectra
of halocidin congeners in this paper, we con¢rmed they retain
strong activities against a wide variety of pathogenic bacteria.
To design an ideal peptide antibiotic with a stronger activity
against multidrug-resistant bacteria and with less hemolytic
activity, we are now examining the biological activities of
diverse synthetic peptides based on the halocidin structure.
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